Van Leeuwen & Company, LLC Danaher Corp Transaction History

Van Leeuwen & Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2024	BUY	$241.42 - $282.29 $603,791 - $706,007	2,501 New	2,501 $663,000
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $7,966 - $9,315	33 Added 1.34%	2,501 $664,000
Q3 2022 Nov 09, 2022	BUY	$247.06 - $1507.4 $609,744 - $3.72 Million	2,468 New	2,468 $637,000
Q4 2020 Feb 16, 2021	SELL	$212.5 - $245.46 $3.3 Million - $3.81 Million	-15,512 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$177.16 - $215.33 $276,546 - $336,130	-1,561 Reduced 9.14%	15,512 $3.34 Million
Q2 2020 Aug 03, 2020	BUY	$128.7 - $176.83 $1.04 Million - $1.43 Million	8,079 Added 89.83%	17,073 $3.02 Million
Q1 2020 Apr 23, 2020	BUY	$121.39 - $169.05 $1.09 Million - $1.52 Million	8,994 New	8,994 $1.25 Million

2,492

540M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $174B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Van Leeuwen & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Van Leeuwen & Company, LLC with notifications on news.